Ursula Hofer
banner
hoferu.bsky.social
Ursula Hofer
@hoferu.bsky.social
Desk-chair virologist, EiC of The Lancet Infectious Diseases, previously at different Nature journals, MD PhD. She/her/expert. Opinions my own.
Pinned
This month's editorial:

Should science be political?

In my mind, there's only one response to this question...

And the more pressing question is, how can politics be more scientific?

www.thelancet.com/journals/lan...
Should science be political?
At this point in time, with US President Trump's administration attacking institutions such as the US CDC, NIH, USAID, WHO, and their people and functions, whether science should be political seems li...
www.thelancet.com
Reposted by Ursula Hofer
New research article

#HIV drug resistance during #antiretroviral therapy scale-up in Uganda, 2012–19: a population-based, longitudinal study

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #ViroSky #AMR #OpenAccess #OA
November 28, 2025 at 9:49 AM
Reposted by Ursula Hofer
New Research

The epidemiology of chikungunya virus in Brazil and the potential impact of vaccines: a mathematical modelling study

www.thelancet.com/journals/lan...
The epidemiology of chikungunya virus in Brazil and the potential impact of vaccines: a mathematical modelling study
Despite widespread circulation, most of Brazil remains susceptible to infection. CHIKV vaccination has the potential to substantially reduce disease burden.
www.thelancet.com
November 28, 2025 at 9:56 AM
If your email has the subject line 'should I close the loop?', I will immediately block you.

PS Hubbie and I lovingly text each other the most outrageous examples of business BS we come across; shared disdain is so much better.
November 28, 2025 at 11:40 AM
Reposted by Ursula Hofer
How does fever work?

Our new Science paper shows how elevated body temperature can protect against severe influenza and that avian-origin viruses escape this defence.

This is likely one reason why bird flus and some pandemic influenzas can be so severe.🧵

www.science.org/doi/10.1126/...
Avian-origin influenza A viruses tolerate elevated pyrexic temperatures in mammals
Host body temperature can define a virus’s replicative profile—influenza A viruses (IAVs) adapted to 40° to 42°C in birds are less temperature sensitive in vitro compared with human isolates adapted t...
www.science.org
November 27, 2025 at 7:55 PM
Reposted by Ursula Hofer
Lifeline is coming to London from 28 March – 2 May 2026! Lifeline stars real-life scientists, healthcare workers, and other heroes working to address the #AMR crisis. If you love performing, apply to be in the show! #IDSky

🔗 Apply to be part of Lifeline: bit.ly/4pnViv7
November 24, 2025 at 5:01 PM
Reposted by Ursula Hofer
Misinformation is one of the world's biggest threats to public health. And governments are not doing enough to protect us.

Social media companies should be held accountable for spreading harmful misinformation in that same way we hold manufacturers responsible for spreading harmful chemicals.
November 24, 2025 at 10:28 AM
Reposted by Ursula Hofer
New comment:

The genomic surveillance gap: averting the antimicrobial resistance pandemic requires global equity and action

www.thelancet.com/journals/lan...
The genomic surveillance gap: averting the antimicrobial resistance pandemic requires global equity and action
The COVID-19 pandemic provided a stark, real-time demonstration of genomic surveillance's power. By sequencing SARS-CoV-2, the global health community tracked viral evolution, identified variants of c...
www.thelancet.com
November 24, 2025 at 8:37 AM
We spend a lot of care and effort on our covers; many editors love working on covers. They have such a symbolic power and are a window into your publication. So, I would like to know who has signed off this cover?
Over many interviews, Robert F. Kennedy Jr. told Michael Scherer about how he plans to remake America’s public-health system. Can he lead the scientific establishment he’s spent much of his life crusading against?

Read more in our new cover story: theatln.tc/q9hXxlbM
November 24, 2025 at 5:56 PM
🧐

Is this AI bias in action?
Why, Adobe, would you depict #Female and #Male hearts this way?

#Its2025 #MedSky #AcademicSky #ScienceSky
November 24, 2025 at 11:00 AM
Reposted by Ursula Hofer
Read our December issue!

Featuring testing obeldesivir for COVID-19 therapy, measles transmission patterns in Italy, and single dose of HPV vaccine in Costa Rica.

www.thelancet.com/issue/S1473-...
November 20, 2025 at 5:51 AM
Reposted by Ursula Hofer
#AMR #Klebsiella cause >100,000 neonatal deaths globally each year.

Our new preprint shows more than half of #Klebsiella pneumoniae neonatal sepsis cases in African and South Asian are nosocomial, acquired through transmission in neonatal units. #WAAW

doi.org/10.1101/2025...
November 19, 2025 at 3:43 PM
This also applies to crazy letters to the editor... Superficially these can look like legitimate letters with references, sometimes even data and stats. Only on close reading you see it's all made up and incoherent. We have a duty to check each of these. Waste of time.
The bigger change is presentation, historically, these emails were visually chaotic: sudden colour changes, ALL CAPS, screenshots pasted at random. Classic signs of disordered thinking. Now they’re neat, structured, and grammatically consistent. The delusion hasn't changed, but the formatting has.
November 19, 2025 at 4:18 PM
Reposted by Ursula Hofer
🌱 New opportunity: We are recruiting a new associate editor for our journal with expertise in viral infections & antiviral therapy. Read our call and apply if you're a good fit! www.cmi-comms.org/article/S295...

⏰ Deadline: 15 Dec 2025

#IDSky #clinmicro #virology #virosky
An open call to join the CMI Communications editorial team: editor in viral infections and antiviral therapy
CMI Communications, the official open-access journal of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), is looking for an editor with strong clinical and research exper...
www.cmi-comms.org
November 18, 2025 at 3:38 PM
Reposted by Ursula Hofer
Dr. Griffin and Vincent Racaniello record from the ASTMH meeting in Toronto for his weekly clinical update! 👇🔗

@danielgriffinmdphd.bsky.social
TWiV 1270: Clinical update with Dr. Daniel Griffin
YouTube video by MicrobeTV
youtu.be
November 17, 2025 at 2:30 PM
Reposted by Ursula Hofer
Epidemiological and virological update on the emerging SARS-CoV-2 variant BA.3.2 - The Lancet Infectious Diseases www.thelancet.com/journals/lan...
Epidemiological and virological update on the emerging SARS-CoV-2 variant BA.3.2
The constant emergence of novel SARS-CoV-2 variants has driven the COVID-19 pandemic and sustains the current endemic. Saltation variants, such as BA.2.86,1 encode highly mutated spike (S) proteins th...
www.thelancet.com
November 17, 2025 at 10:55 AM
Reposted by Ursula Hofer
Important new analysis identifying the scope of clinical trials disrupted because of NIH shenanigans.

> 74 thousand trial participants affected

jamanetwork.com/journals/jam...

1/4
Clinical Trials Affected by Research Grant Terminations at the National Institutes of Health
This cross-sectional study summarizes the number of trials with terminated grants from the National Institutes of Health (NIH) and calculates the proportion of affected trials among those with previou...
jamanetwork.com
November 17, 2025 at 5:45 PM
London can be beautiful.
November 17, 2025 at 9:56 AM
Reposted by Ursula Hofer
Post-TB lung disease - the impact of TB on patients does not end with the course of antibiotics, characterised by substantial long-term pulmonary impairment.

Proposed case definition to support assessments and interventions in research studies 👇

#TBSky #IDSky @thelancetinfdis.bsky.social
Post-tuberculosis lung disease: a case definition for use in research studies
Despite growing awareness of the substantial burden of long-term pulmonary impairment among tuberculosis survivors, marked variability in how post-tuberculosis lung disease is defined across research ...
www.thelancet.com
November 17, 2025 at 8:47 AM
Reposted by Ursula Hofer
🎙️ Just published: Communicable E40: AMR in conflict and crisis zones

Hosted by Nav Narayanan & Thomas Tängdén

w/ invited guests Aula Abbara (UK), Guido Granata (Italy), Tuomas Aro (Finland)

Listen on #Communicable:

#IDSky #Clinmicro #WAAW2025 #AMR @taescmid.bsky.social
Communicable E40: AMR in conflict and crisis zones
It’s World AMR Awareness Week (WAAW) and we have prepared a special...
share.transistor.fm
November 16, 2025 at 11:00 PM
Reposted by Ursula Hofer
Gender differences in audience participation at infectious disease & microbiology conferences: a prospective observational study

@sarah-delliere.bsky.social #IDSky

Men overrepresented among audience participants during ID /micro meetings

www.clinicalmicrobiologyandinfection.org/article/S119...
November 14, 2025 at 1:31 PM
Reposted by Ursula Hofer
📣 How many healthy people in a high-income, low-resistance country will be #ESBL carriers? In this prospective cohort of >700 adults with no at-risk travel history, whole genome sequencing showed 5% prevalence. It was all #Ecoli.

#IDSky #clinmicro #MedSky #OA

www.cmi-comms.org/article/S295...
Carriage of extended-spectrum β-lactamase–producing Enterobacterales among healthy adults: a cohort study in Finland
Despite increasing antimicrobial resistance (AMR) in clinical samples in high-income countries, data on healthy community dwellers remains limited. We explored the prevalence and types of extended-spe...
www.cmi-comms.org
November 13, 2025 at 9:33 AM
Reposted by Ursula Hofer
Still some way to go for mpox RAT; sensitivity not quite there yet, in particular in children and early in the disease course.
November 13, 2025 at 10:50 AM